About Boris Minev
Form D filings for Calidi Biotherapeutics from 2023 to 2024 list Boris Minev as interim chief medical officer.
Boris Minev reports to the SEC as an officer of 1 public company.
Boris Minev first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Boris Minev in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Boris Minev works with at each company, as listed on that company's latest Form D.
Calidi Biotherapeutics, Inc. · Form D, Jun 29, 2023
AC
Allan Camaisa
CEO and director
HL
Heehyoung Lee
Director
JS
James Schoeneck
Director
AZ
Alfonso Zulueta
Director
AS
Anthony Santidrian
Executive officer
ST
Stephen Thesing
Chief Business Officer
TK
Tony Kalajian
Interim Chief Financial Officer
AP
Amish Patel
Vice President of Technical Operations
DS
David Sans
Chief of Corporate Development
WP
Wendy Pizarro
Executive officer
SL
Scott Leftwich
Director
GN
George Ng
Director